Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: A systematic review

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 7, 2013, Pages 830-841

  Ren, Weirong ^a   Qi, Xingshun ^a   Yang, Zhiping ^a   Han, Guohong ^a   Fan, Daiming ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Budd?Chiari syndrome; hepatocellular carcinoma; prevalence; risk factors; systematic review

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ALCOHOL CONSUMPTION; ARTICLE; ASIA; BUDD CHIARI SYNDROME; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; JAPANESE; LIVER CELL CARCINOMA; LIVER VEIN OBSTRUCTION; MEDLINE; MUTATIONAL ANALYSIS; PORTAL VEIN BLOOD PRESSURE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOUTH AFRICA; SYSTEMATIC REVIEW; UNITED STATES; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; BUDD-CHIARI SYNDROME; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CHILD; CONSTRICTION, PATHOLOGIC; FACTOR V; FEMALE; HEPATIC VEINS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEX FACTORS; VENA CAVA, INFERIOR; VENOUS PRESSURE; YOUNG ADULT;

EID: 84879892225     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835eb8d4     Document Type: Article

References (46)

1. Valla DC Primary Budd-Chiari syndrome. J Hepatol 2009; 50:195-203.
2. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38:364-371.
3. Valla DC The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003; 38:793-803.
4. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009; 151:167-175.
5. Valla DC Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut 2008; 57:1469-1478.
6. Plessier A, Valla DC Budd-Chiari syndrome. Semin Liver Dis 2008; 28:259-269.
7. De Leve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49:1729-1764.
8. Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther 2011; 33: 1087-1103.
9. Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995; 22:1-9.
10. Shin SH, Chung YH, Suh DD, Shin JW, Jang MK, Ryu SH, et al. Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2004; 16:319-324.
11. Wang ZG, Zhang FJ, Yi MQ, Qiang LX. Evolution of management for Budd-Chiari syndrome: a team's view from 2564 patients. ANZ J Surg 2005; 75:55-63.
12. Simson IW. Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 1982; 82: 171-178.
13. Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996; 11:170-179.
14. Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 2012; 27:1036-1043.
15. Lin GL, Xu PQ, Qi H, Lian JH, Zheng H, Dang XW. Relations of Budd-Chiari syndrome to prothrombin gene mutation. Hepatobiliary Pancreat Dis Int 2004; 3:214-218.
16. Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, et al. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patientswith Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013; 28:148-152.
17. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379:1245-1255.
18. Altekruse SF, Mc Glynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27:1485-1491.
19. Lambert MP, Paliwal A, Vaissiere T, Chemin I, Zoulim F, Tommasino M, et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBVand HCV infection and alcohol intake.J Hepatol 2011; 54:705-715.
20. Stickel F, Hampe J. Genetic determinants of alcoholic liver disease. Gut 2012; 61:150-159.
21. Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010; 24:695-708.
22. Xu L, Qian G, Tang L, Su J, Wang JS. Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China. J Hepatol 2010; 53:671-676.
23. Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology 2012; 56:1409-141 7.
24. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
25. Ren W, Qi X, Jia J, Yang M, Han G. Hepatocellular carcinoma. Lancet 2012; 380:469author reply 70-71.
26. Simson IW. The causes and consequences of chronic hepatic venous outflow obstruction. S Afr Med J 1987; 72:11-14.
27. Sakugawa H, Higashionna A, Oyakawa T, Kadena K, Kinjo F, Saito A. Ultrasound study in the diagnosis of primary Budd-Chiari syndrome (obstruction of the inferior vena cava). Gastroenterol Jpn 1992; 27: 69-77.
28. Rector WG Jr, Xu YH, Goldstein L, Peters RL, Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore) 1985; 64:134-143.
29. Park H, Yoon JY, Park KH, Kim do Y, Ahn SH, Han KH, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea. World J Gastroenterol 2012; 18:1946-1952.
30. Moucari R, Rautou PE, Cazals-Hatem D, Geara A, Bureau C, Consigny Y, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and riskfactors. Gut 2008; 57:828-835.
31. Lee BB, Villavicencio L, Kim YW, Do YS, Koh KC, Lim HK, et al. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg 2006; 43:101-108.
32. Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994; 73:21-36.
33. Bayraktar Y, Egesel T, Saglam F, Balkanci F, Van Thiel DH. Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma? J Clin Gastroenterol 1998; 27:67-71.
34. Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, et al. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. J Gastroenterol Hepatol 2007; 22:1921-1928.
35. Shrestha SM. Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava. Hepatol Int 2009; 3:392-402.
36. Seo JB, Chung JW, Park JH, Kim SH, Kim TK, Han JK, et al. Benign obstruction of the hepatic inferior vena cava complicated by hepatocellular carcinoma: combined interventional management. Am J Roentgenol 1998; 170:655-659.
37. Nakamura S, Takezawa Y. Obstruction of the inferior vena cava in the hepatic portion and hepatocellular carcinoma. Tohoku J Exp Med 1982; 138:119-120.
38. Matsui S, Ichida T, Watanabe M, Sugitani S, Suda T, Takahashi T, et al. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol 2000; 15:1205-1211.
39. Lu CL, Chou YH, Hwang SJ, Chan CY, Lee SD. Membranous obstruction of inferior vena cava in Taiwan. J Gastroenterol Hepatol 1995; 10: 287-294.
40. Kew MC, Mc Knight A, Hodkinson J, Bukofzer S, Esser JD. The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 1989; 9:121-125.
41. Gwon D 2nd, Ko GY, Yoon HK, Sung KB, Kim JH, Lee SS, et al. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE. Radiology 2010; 254:617-626.
42. Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. Celiac disease. Evid Rep Technol Assess (Summ) 2004;1-6.
43. Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, et al. Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 1999; 210:443-450.
44. Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol 2008; 14:278-285.
45. Plessier A, Rautou PE, Valla DC Management of hepatic vascular diseases. J Hepatol 2012; 56 (Suppl 1):S25-S38.
46. Kew MC, Hodkinson HJ. Membranous obstruction of the inferior vena cava and its causal relation to hepatocellular carcinoma. Liver Int 2006; 26:1-7.